and older. Hence, we are left with the blanket statement that children are spared from severe COVID-19, an argument that is currently being used in many European countries, including the UK and Germany, to not vaccinate adolescents. Although few children become severely ill from SARS-CoV-2 infection compared with adults, the increasing number of delta variant infections will most likely result in preventable morbidity and mortality in this age group. Therefore, we call not only for pediatric clinical trials of antiviral drugs but, more importantly, for universal access to COVID-19 immunization for children and adolescents as safe and effective vaccines become licensed and available. 5